The mode of action of this drug can be related to the endo-lysosomal trafficking regulation of integrins and ADRB2, the AMPc intracellular accumulation and SRSF6 alternative splicing regulation, which seemed to be central in integrin-dependent both collective and single IGDQ-induced cancer cell migration. Here, ADRB2 is linked to cancer.